Ser234Leu missense mutation in the A1 domain of factor v causing moderate factor v deficiency in a Chinese family

Pathology

Volumn 41, Issue 6, 2009, Pages 566-571

  Jin, Pei Pei ^a   Wang, Xue Feng ^a   Ding, Qiu Lan ^a   Fu, Qi Hua ^b   Cai, Xiao Hong ^a   Shen, Li Song ^a   Wang, Hong Li ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Coagulation factor V; Deficiency; Expression study; Gene mutation

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 5; COMPLEMENTARY DNA; PROTHROMBIN; THROMBIN; THROMBOPLASTIN;

ADULT; ANIMAL CELL; ARTICLE; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CHINESE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; IMMUNOFLUORESCENCE; MALE; MISSENSE MUTATION; NONHUMAN; SITE DIRECTED MUTAGENESIS;

EID: 70350648028     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020903072734     Document Type: Article

References (23)

1. Dahlback B. Blood coagulation. Lancet 2000; 355: 1627-1632
2. Mann KG, Kalafatis M. Factor V: a combination of Dr Jekyll and Mr Hyde. Blood 2003; 101: 20-30.
3. Foster WB, Nesheim ME, Mann KG. The factor Xa-catalyzed activation of factor V. J Biol Chem 1983; 258: 13970-13977
4. Suzuki K, Dahlback B, Stenffo J. Thrombin-catalyzed activation of human coagulation factor V. J Biol Chem 1982; 257: 6556-6564
5. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 1994; 269: 31869-31880
6. Owren PA. New factors concerned in the coagulation of blood. Bull Schweiz Akad Med Wiss 1947; 3: 163-177
7. Castaman G, Lunghi B, Missiaglia E, et al. Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299Arg substitutions in factor V. Br J Haematol 1997; 99: 257-261
8. Guasch JF, Lensen RP, Bertina RM. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is 'pseudo homozygous' for activated protein C resistance. Thromb Haemost 1997; 77: 252-257
9. Lunghi B, Castoldi E, Mingozzi F, et al. A novel factor V null mutation detected in a thrombophilia patient with pseudo homozygous APC-resistance and in an asymptomatic unrelated subject. Blood 1998; 92: 1463-1464
10. Castoldi E, Kalafatis M, Lunghi B, et al. Molecular bases of pseudohomozygous APC resistance: the compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma. Thromb Haemost 1998; 80: 403-406
11. Zehnder JL, Hiraki DD, Jones CD, et al. Familial coagulation factor V deficiency caused by a novel 4 base pair insertion in the factor V gene: factor V Stanford. Thromb Haemost 1999; 82: 1097-1099
12. Steen M, Miteva M, Villoutreix BO, et al. Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized. Blood 2003; 102: 1316-1322
13. Enjolras N, Plantier JL, Rodriguez MH, et al. Two novel mutations in EGF-like domains of human factor IX dramatically impair intracellular processing and secretion. J Thromb Haemost 2004; 2: 1143-1154
14. Asselta R, Tenchini ML, Duga S. Inherited defects of coagulation factory V : the hemorrhagic side. J Thromb Haemost 2006; 4: 26-34.
15. Zhou RF, Fu QH, Wang WB, et al. Molecular mechanisms of antithrombin deficiency in two Chinese families. One novel and one recurrent point mutation in the antithrombin gene causing venous thrombosis. Thromb Haemost 2005; 94: 1172-1176
16. Chen TY, Lin TM, Chen HY, et al. Gly392Cys missense mutation in the A2 domain of factor V causing severe factor V deficiency: molecular characterization by expression of the recombinant protein. Thromb Haemost 2005; 93: 614-615
17. Duga S, Montefusco MC, Asselta R, et al. Arg2074Cys missense mutation in the C2-domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the recombinant protein. Blood 2003; 101: 173-177
18. Montefusco MC, Duga S, Asselta R, et al. Clinical and molecular characterization of 6 patients a.ected by severe deficiency of coagulation factor V: Broadening of the mutational spectrum of factor V gene and in vitro analysis of the newly identified missense mutations. Blood 2003; 102: 3210-3216
19. Yamakage N, Ikejiri M, Okumura K, et al. A case of coagulation factor V deficiency caused by compound heterozygous mutations in the factor V gene. Haemophilia 2006; 12: 172-178
20. Steen M, Villoutreix BO, Norstrom EA, et al. De.ning the factor Xabinding site on factor Va by site-directed glycosylation. J Biol Chem 2002; 277: 50022-50029
21. Heeb MJ, Kojima Y, Hackeng TM, et al. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va. Prot Sci 1996; 5: 1883-1889
22. Kojima Y, Heeb MJ, Gale AJ, et al. Binding site for blood coagulation factor Xa involving residues 311-325 in factor Va. J Biol Chem 1998; 273: 14900-14905
23. Kalafatis M, Beck DO. Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323-331 of factor V represent an interactive site for activated factor X. Biochemistry 2002; 41: 12715-12728